ANTI-21-HYDROXYLASE ANTIBODY - ANVISA Registration 80464810575
Access comprehensive regulatory information for ANTI-21-HYDROXYLASE ANTIBODY in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80464810575 and manufactured by MEDIPAN GMBH. The registration is held by ARGOSLAB DISTRIBUIDORA DE PRODUTOS PARA LABORATÓRIOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
80464810575
25351722111201778
09377976000152
Company Information
Dates and Status
Jun 04, 2018
VIGENTE
09/18/2025 19:00:01
ANTI-PANCREATIC ISLET CELL ANTIBODY
Medizym® anti-IA2 M
MEDIPAN
80464810725
Nov 05, 2020
ANTI-TSH RECEPTOR ANTIBODY (TRAb)
MediZym ® T.R.A. human
MEDIPAN
80836930084
Nov 05, 2018
ANTI-GLUTAMIC ACID DECARBOXYLASE (GAD) ANTIBODY
Medizym® anti-GAD M
MEDIPAN
80464810723
Oct 29, 2020
ANTI-INSULIN ANTIBODY
TESTE PARA ANTICORPOS ANTI IA2
RSR LTD.
10337680036
May 06, 1999
ANTI-INSULIN ANTIBODY
AUTOIMMUNE DIABETES MULTI CONTROL
SHENZHEN YHLO BIOTECH CO., LTD.
80867150116
Jul 29, 2021